KAITLYN BENJAMIN: Open Payments
NPI 1144729518 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,651 in 65 payments from 18 companies in 2025. Trend: 2023 $2,988 · 2024 $2,030 · 2025 $1,651
Food & beverage: $1,651
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $294 |
| Incyte Corporation | 12 | $245 |
| Arcutis Biotherapeutics, Inc. | 6 | $201 |
| E.R. Squibb & Sons, L.L.C. | 3 | $166 |
| Kerecis Limited | 1 | $155 |
| Janssen Biotech, Inc. | 7 | $151 |
| PFIZER INC. | 4 | $82 |
| Lilly USA, LLC | 2 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $47 |
Products named: OPZELURA, Zoryve, SKYRIZI, Sotyktu, Kerecis SurgiClose, TREMFYA, RINVOQ, CIBINQO.
Industry payments across FL — which companies pay providers there.
